Study # 2250

Population:

Healthy, Recreational OPIOID users; Males and non-pregnant Females, 18-55 years of age; free of daily medications.

Study Details:

3 visits (Screening/ Qualification/ Treatment/ Follow-up).  Compensation is up to $7000 for completing the entire study.

NOTE:  Files will not be hold-dated for self-reported opioid use.

Visit 2:  20-days (19-nights) continuous in-clinic stay

Study Date

VISIT 1 – SCREENING VISIT
VISIT 2 – QUALIFICATION PHASE
Clinic Admission/ Naloxone Challenge Friday June 29, 2018 @ 8 am
Qualification Dose 1 Saturday June 30, 2018
Qualification Dose 2 Sunday July 01, 2018
Exit – Qualification Failures OR In-clinic (non-dose) – Qualification Passes Monday July 02, 2018 @ 12 noon
VISIT 2 – TREATMENT PHASE (continued)
In-clinic (non-dose) Tuesday July 03, 2018
Treatment Dose 1 Wednesday July 04, 2018
In-clinic (non-dose) Thursday July 05, 2018
In-clinic (non-dose) Friday July 06, 2018
Treatment Dose 2 Saturday July 07, 2018
In-clinic (non-dose) Sunday July 08, 2018
In-clinic (non-dose) Monday July 09, 2018
Treatment Dose 3 Tuesday July 10, 2018
In-clinic (non-dose) Wednesday July 11, 2018
In-clinic (non-dose) Thursday July 12, 2018
Treatment Dose 4 Friday July 13, 2018
In-clinic (non-dose) Saturday July 14, 2018
In-clinic (non-dose) Sunday July 15, 2018
Treatment Dose 5 Monday July 16, 2018
In-clinic (non-dose) Tuesday July 17, 2018
Exit – Treatment Wednesday July 18, 2018 @ 12 noon
VISIT 3 – FOLLOW-UP
Post Study Follow-up Saturday, July 21, 2018

Post Study Visit:

N/A

Additional Info:

Morning drug administration on an empty stomach

Contact:

Toll Free 1-833-879-2774 or (416) 747-5246